Alan Warrander
Plus aucun poste en cours
Provenance du réseau au premier degré de Alan Warrander
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Incanthera Plc
 Incanthera Plc Pharmaceuticals: MajorHealth Technology Incanthera Plc operates as a holding company, which focuses on drug discovery and development of targeted medicines for the treatment of cancer. The firm products include Sol, EP0015, Equin & Duo-C. The company was founded on March 2, 2010 and is headquartered in Manchester, the United Kingdom.
5
| Public Company | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alan Warrander via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Incanthera Research & Development Ltd.
 Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Medical Distributors | Chairman Chief Executive Officer Chief Operating Officer | |
| Incanthera Therapeutics Ltd. | Director/Board Member Chief Executive Officer | ||
Spear Therapeutics Ltd.
 Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Incanthera Oncology Ltd.
 Incanthera Oncology Ltd. Medical DistributorsDistribution Services Incanthera Oncology Ltd. engages in the provision of drug development services. The company was founded on April 7, 2011 and is headquartered in Manchester, the United kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Iqure Pharma, Inc.
 Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
| University of Salford | College/University | Corporate Officer/Principal | |
| Politechnika Gdanska | College/University | Undergraduate Degree | |
Medipex Ltd.
 Medipex Ltd. Miscellaneous Commercial ServicesCommercial Services Medipex Ltd. provides technology and knowledge transfer services to the National Health Service. It provides a range of services to NHS organizations to help them identify, protect and commercialize Intellectual Property owned by them through the work of their employees. The company was founded in 2002 and is headquartered in Leeds, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
| London School of Hygiene & Tropical Medicine | College/University | Graduate Degree | |
Association of Chartered Certified Accountants
 Association of Chartered Certified Accountants Miscellaneous Commercial ServicesCommercial Services The Association of Chartered Certified Accountants (ACCA) is a professional body for accountants. The non-profit company is based in Glasgow, UK, and has subsidiaries in Mauritius, United Kingdom, and Hong Kong. The British company offers a program called ALP-C, which approves learning materials from high-quality content providers to support studying towards ACCA's qualification. The role of the CFO is evolving beyond finance to include reporting on value-centric aspects of their operations, as companies move towards sustainable practices. The CEO of the company is Helen Joanna Brand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| 4BASEBIO PLC | Biotechnology | Chairman | |
| Frangipani Dreams Ltd. | Director/Board Member | ||
| Incanthera R&D Ltd. | Director/Board Member | ||
| Wise Old Owl Ltd. | Director/Board Member | ||
| Dropped Ltd. | Chairman | ||
| ARK Analytics Solutions Ltd. | Chairman | ||
| Unnamed Ltd. | Director/Board Member | ||
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Chief Executive Officer | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member | |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| Cranfield School of Management | College/University | Masters Business Admin | |
| IMMUPHARMA PLC | Pharmaceuticals: Other | Chief Executive Officer | |
| BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Comptroller/Controller/Auditor |
Statistiques
Internationale
| Royaume-Uni | 27 |
| Etats-Unis | 2 |
| Pologne | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 17 |
| Chairman | 7 |
| Chief Executive Officer | 7 |
| Founder | 4 |
| Director of Finance/CFO | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Alan Warrander
- Connexions Sociétés
